JohnMichaelSchreiberMD

Child Neurology • Fairfax, VA

Physician

Join to view full profile

Dr. Schreiber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schreiber's full profile

Already have an account?

Office
3023 Hamaker Ct
300
Fairfax, VA 22031
Phone+1 703-876-2788

Fax+1 703-839-8798

Education & Training

Children's National Hospital/George Washington UniversityFellowship, Child Neurology, 2008
National Capital ConsortiumFellowship, Clinical Neurophysiology, 2012 - 2013
Children's National Hospital/George Washington UniversityResidency, Child Neurology, 2008 - 2011
Children's National HospitalResidency, Pediatrics, 2006 - 2008
University of Maryland School of MedicineClass of 2006

Certifications & Licensure

VA State Medical License 2013 - 2026
DC State Medical License 2013 - 2025
MD State Medical License 2011 - 2025
FL State Medical License 2017 - 2019
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology
American Board of Psychiatry and Neurology Epilepsy

Clinical Trials

A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome Start of enrollment: 2021 Nov 08
Completed
Phase 3
Roles: Principal Investigator
A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome Start of enrollment: 2021 Oct 28
Completed
Phase 3
Roles: Principal Investigator

Publications & Presentations

PubMed

Deletions in the CDKL5 5' untranslated region lead to CDKL5 deficiency disorder.
Isabel Haviland, Ralph D Hector, Lindsay C Swanson, Aubrie Soucy Verran, Emma Sherrill
American Journal of Medical Genetics. Part A. 2025-01-01
Expert opinion on use of vagus nerve stimulation therapy in the management of pediatric epilepsy: A Delphi consensus study.
James W Wheless, Jeffrey S Raskin, Anthony L Fine, Kelly G Knupp, John Schreiber
Seizure. 2024-12-01
Patients carrying pathogenic SCN8A variants with loss- and gain-of-function effects can be classified into five subgroups exhibiting varying developmental and epilepti...
Joshua B Hack, Joseph C Watkins, John M Schreiber, Michael F Hammer
Epilepsia. 2024-11-01

Press Mentions

In the News: The Role of Genetic Testing in Pediatric Epilepsy Diagnosis and TreatmentJanuary 2nd, 2025
Legal Effect of MisdiagnosisApril 7th, 2022